Mohebbi, A., Ebrahimi, M., Askari, F., Shaddel, R., Mirarab, A., Oladnabi, M. QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors. 2022 p. 197-206,.
Mohebbi, A., Ebrahimi, M., Askari, F., Shaddel, R., Mirarab, A., Oladnabi, M. QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors. 2022 p. 197-206,.
Mohebbi, A., Ebrahimi, M., Askari, F., Shaddel, R., Mirarab, A., Oladnabi, M. (2022) QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors, p. 197-206,.
Mohebbi, A., Ebrahimi, M., Askari, F., Shaddel, R., Mirarab, A., & Oladnabi, M. (2022). QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors. p. 197-206.
Mohebbi A, Ebrahimi M, Askari F, Shaddel R, Mirarab A, Oladnabi M. QSAR Modeling of a Ligand-Based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors. 2022. p. p. 197-206.